Prestige Consumer Healthcare PBH
$49.63 +$0.03 (+0.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $49.63 0.00%
Open$49.85
Prev close$49.60
Day range$49.43 – $51.23
Volume612.4K
Market cap$2.35B
P/E (TTM)15.3
Dividend yield–
PBH Stock News
Headlines matching Prestige Consumer Healthcare or the PBH ticker, most recent first.
- CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $72
- Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF) and Prestige Consumer Healthcare (PBH)
- William Blair Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating
- 8-K: Prestige Consumer Healthcare | 8-K: Current report
- Prestige Consumer Healthcare | 4: Statement of changes in beneficial ownership of securities
- 10-Q: Prestige Consumer Healthcare | 10-Q: Q1 2027 Earnings Report
- Prestige Consumer Healthcare | 4: Statement of changes in beneficial ownership of securities
- Prestige Consumer Healthcare Lifts Outlook After Strong Q1 Positive
- Prestige Consumer Healthcare | 8-K: Current report
- Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference Positive
- Prestige Consumer Healthcare Inc. (PBH) Clear Eyes and Pillar5 Problems Drive Stock Lower, HBSS Investigating
- Research Alert: Pbh Q1: Revenue Up 25% To Cad2.1b On Stampede Deal; Maintains 2026 Guidance
- Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $65
- Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $65 From $77, Maintains Outperform Rating Positive
- CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $72 Negative
No comments yet — be the first to weigh in on PBH.
Sign in to join the discussion.